ArticleUpdates in surgery2026
Clinical and biological impact of conversion on outcomes of minimally invasive liver surgery: a multimodal analysis.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Minimally invasive liver surgery (MILS) offers several advantages over open liver surgery (OLS), but the underlying mechanisms remain unclear. This study compares inflammatory marker levels between OLS and MILS and examines the impact of conversion. Patients undergoing liver resection at San Raffaele Hospital (September 2022-May 2023) were prospectively enrolled. Plasma inflammatory markers were measured over 120 postoperative hours and analyzed between cohorts. Among 118 liver resections (50 laparoscopic, 38 robotic, 30 open), the OLS group showed higher intraoperative plasma lactate (4.6 vs. 3.8 mmol/L; p < 0.04) and levels one hour postoperatively (3.9 vs. 2.4 mmol/L; p = 0.02). CRP and IL-6 levels were significantly higher in OLS (p < 0.001). No significant differences were found between laparoscopic and robotic approaches. However, conversion led to increased lactate (p = 0.018), CRP (p < 0.05), and IL-6 (p < 0.001) also compared with upfront OLS. MILS significantly improves biological markers as compared to OLS. However, conversion not only negates these benefits but also amplifies surgical stress and inflammation.
Indexed as
Identifiers
40828219What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.